LITTLE ROCK, Ark. – A pharmaceutical company has been ordered to pay over $238,000 to settle a multistate lawsuit alleging the underpayment of Medicaid drug rebates.
According to the Arkansas attorney general’s office, Mallinckrodt ARD, LLC, formerly known as Questcor Pharmaceuticals, Inc. was ordered to pay $233 million, plus interest, to be paid over a period of seven years to 50 states who were part of the lawsuit. In total, Arkansas will receive $238,515.92.
“For over seven years, Mallinckrodt knowingly and illegally underpaid Medicaid rebates costing the State and taxpayers,” said Attorney General Leslie Rutledge.
Mallinckrodt’s U.S. headquarters is in Bedminster, New Jersey. The settlement resolves allegations that from January 1, 2013, through June 30, 2020, Mallinckrodt knowingly underpaid Medicaid rebates due for its drug H.P. Acthar Gel (Acthar).
The lawsuit alleges that Mallinckrodt’s conduct violated the Federal False Claims Act and the Arkansas Medicaid Fraud False Claims Act and resulted in the submission of false claims to the Arkansas Medicaid program.
This settlement results from a whistleblower lawsuit originally filed in the United States District Court for the District of Massachusetts.
A team from the National Association of Medicaid Fraud Control Units participated in the litigation and conducted settlement negotiations on behalf of the states